Olpha

Olpha, a subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in producing medicines and chemical pharmaceuticals. Its portfolio includes 60 formulations, 25 APIs, and over 20 intermediates, covering nervous system, cardiovascular, antiviral, antibacterial, and anti-allergic drugs. Olpha’s products enhance access to essential medicines and support its global growth and reputation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.